There was also a trend toward the reduction of fibrosis as evaluated by Picrosirius Red staining and NASH fibrosis staging (Fig. 3A,B), as well as Timp1 mRNA expression (see Supplementary Fig. S2 online), in the livers of clodronate-treated mice. The gene discussed is TIMP1; the disease is metabolic dysfunction-associated steatohepatitis.